WO2023110900 - ORAL CARE COMPOSITION COMPRISING ENZYMES
National phase entry:
Publication Number
WO/2023/110900
Publication Date
22.06.2023
International Application No.
PCT/EP2022/085665
International Filing Date
13.12.2022
Title **
[English]
ORAL CARE COMPOSITION COMPRISING ENZYMES
[French]
COMPOSITION DE SOINS BUCCODENTAIRES COMPRENANT DES ENZYMES
Applicants **
NOVOZYMES A/S
Inventors
TIWARI, Manish, Kumar
PALMÉN, Lorena, González
SEGURA, Dorotea, Raventos
JOERGENSEN, Mette, Rose
Priority Data
PA202101210
16.12.2021
DK
22182251.3
30.06.2022
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2531 | |
| EPO | Filing, Examination, Granting | 10009 | |
| Japan | Filing, Examination, Granting | 2201 | |
| South Korea | Filing, Examination, Granting | 2055 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
21,536
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present invention relates to an enzymatic oral care composition comprising a DNase, a mutanase, a beta-glucanase, and at least one oral care ingredient. The invention further relates to the use of said composition as a medicament, use of said composition in treatment of oral disease, methods of treatment comprising administering said composition to a human subject, methods of removing biofilm comprising contacting an object with said composition, and kits of parts comprising said composition.[French]
La présente invention concerne une composition de soins buccodentaires enzymatique comprenant une DNase, une mutanase, une bêta-glucanase et au moins un ingrédient de soins buccodentaires. L'invention concerne en outre l'utilisation de ladite composition en tant que médicament, l'utilisation de ladite composition dans le traitement d'une maladie buccodentaire, des procédés de traitement comprenant l'administration de ladite composition à un sujet humain, des procédés d'élimination de biofilm comprenant la mise en contact d'un objet avec ladite composition, et des kits de pièces comprenant ladite composition.